SIREN : 843017443
MEDGIR is a French company founded 7 years ago, specialized in the sector Gestion de fonds. Based in BRON (69500), this company of category PME shows in 2025 a revenue of 14 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-04-18
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 14 044 € | 11 112 € | N/C | N/C | N/C | N/C | N/C |
| Net income | 745 687 € | 511 786 € | 309 715 € | 233 570 € | 260 621 € | 145 347 € | -4 275 € |
| EBITDA | -8 690 € | -6 764 € | -2 819 € | -2 323 € | -1 983 € | -2 172 € | -4 275 € |
| Net margin | 5309.6% | 4605.7% | N/C | N/C | N/C | N/C | N/C |
In 2025, MEDGIR achieves revenue of 14 k€. Over the period 2024-2025, the company shows strong growth with a CAGR (compound annual growth rate) of +26.4%. Vs 2024, growth of +26% (11 k€ -> 14 k€). After deducting consumption (0 €), gross margin stands at 14 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -9 k€, representing -61.9% of revenue. Negative EBITDA means operations do not cover current expenses: concerning situation. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 746 k€, i.e. 5309.6% of revenue. This profit can be retained or distributed to shareholders.
14 044 €
14 044 €
-8 690 €
-23 865 €
745 687 €
-61.9%
The debt ratio (= Financial debt / Equity x 100) stands at 5%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 92%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.3 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 5433.2% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
5.379%
91.759%
5433.181%
0.281
90.3%
In 2025, the debt ratio of MEDGIR (5.38) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2025, the financial autonomy of MEDGIR (91.8%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
In 2025, the repayment capacity of MEDGIR (0.28) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 969.55. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
969.55
-25.029
In 2025, the liquidity ratio of MEDGIR (969.55) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2025, the interest coverage of MEDGIR (-25.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 9 days. Favorable situation: supplier credit is longer than customer credit by 9 days. Overall, WCR represents 16198 days of revenue, i.e. 632 k€ to permanently finance.
631 883 €
0 j
9 j
0 j
16198 j
Indicative estimate only : the number of comparable transactions in this sector is limited (40 transactions). This range of 388 386€ to 2 247 060€ is provided for information purposes only and requires in-depth analysis to be confirmed.
This estimate is based on the analysis of 40 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare MEDGIR with other companies in the same sector:
The revenue of MEDGIR in 2025 is 14 k€.
Yes, MEDGIR generated a net profit of 746 k€ in 2025.
The headquarters of MEDGIR is located in BRON (69500), in the department Rhone.
The tax return of MEDGIR is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
MEDGIR operates in the sector Gestion de fonds (NAF code 66.30Z). See the 'Sector positioning' section above to compare the company with its competitors.